Istraživači
Srdić-Rajić, Tatjana
Rezultati 41-60 od 185
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2022 | Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention | Ružić, Dušan   ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Echeverria, Cesar; Nikolić, Katarina ; Santibanez, Juan | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2022 | Novel protocol for enhanced sampling of binding pocket dynamics and its integration into the sirtuin 2 inhibitors virtual screening campaign | Đoković, Nemanja ; Ružić, Dušan ; Rahnasto‐Rilla, Minna; Srdić-Rajić, Tatjana ; Lahtela‐Kakkonen, Maija; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Nischarin receptor agonist rilmenidine decreases production of pro-tumorigenic cytokines and growth factors in pancreatic ductal adenocarcinoma stellate cells | Živić, Kristina ; Ostojić, Marija ; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Danijel Galun ; Jelena Grahovac | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors | Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Mališić, Emina ; Rajić, Tatjana Srdić- ; Miletić, Nevena Tišma ; Babović, Nada ; Jurišić, Vladimir | Article | 22M22 |
| 2021 | Potential anti-MDR effect of rilmenidine in pancreatic ductal adenocarcinoma | Ostojić, Marija ; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Živić, Kristina ; Jelena Grahovac | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | RATIONAL DESIGN, SYNTHESIS AND IN VITRO TESTING OF - SELECTIVE HDAC6 AND SIRT2 INHIBITORS | Dusan Ruzic ; Đoković, Nemanja B. ; Milos Petkovic ; Danica Agbaba ; Sheraz Gul; Maija Lahtela-Kakkonen; A. Ganesan; Juan F. Santibanez; Tatjana Srdic-Rajic ; Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2021 | Rational design, synthesis and in vitro testing of selective HDAC6 and SIRT2 inhibitors | Ružić, Dušan ; Đoković, Nemanja ; Petković, Miloš ; Agbaba, Danica ; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Santibanez, Juan ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | Anti-migratory properties of Nischarin agonist rilmenidine in pancreatic ductal adenocarcinoma | Živić, Kristina ; Marija Ostojićc; Pavlović, Marijana ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | Potential anti-metastatic activity of Imidazoline I1 receptor agonists in Pancreatic Ductal Adenocarcinoma | Živić, Kristina ; Pavlovic, Marijana ; Ostojić, Marija ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Conference Paper | Mp. category will be shown later |
| 2021 | In Vitro Study of Two Edible Polygonoideae Plants: Phenolic Profile, Cytotoxicity, and Modulation of Keap1-Nrf2 Gene Expression | Jovanović, Marina ; Tenji, Dina ; Nikolić, Biljana ; Srdić-Rajić, Tatjana ; Svirčev, Emilija ; Mitić-Ćulafić, Dragana | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2021 | Drug repurposing in pancreatic ductal adenocarcinoma | Jelena Grahovac ; Živić, Kristina ; Pavlović, Marijana ; Ostojić, Marija ; Danijel Galun ; Srdić-Rajić, Tatjana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | SHORT TALK 129 Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients | Martinovic, Mirjacic Katarina ; Vuletić, Ana ; Mališić, Emina ; Rajić, Tatjana Srdić- ; Miletić, Nevena Tišma ; Babović, Nada ; Jurišić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2021 | Nischarin as a target for drug repurposing in solid tumors | Ostojić, Marija ; Pavlović, Marijana ; Živić, Kristina ; Srdić-Rajić, Tatjana ; Jelena Grahovac | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors | Ruzic, Dušan ; Đoković, Nemanja B. ; Bon C.; Petkovic, M. ; Ellinger B.; Gul, S.; Santibanez F. J.; Lahtela-Kakkonen, M.; Halby L.; Ganesan, A.;
Srdic-Rajic T.
; Arimondo P.; Nikolić, Katarina M. ; | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivatives | Dusan Ruzic ; Milos Petkovic ; E. Bernhard; Sheraz Gul; J.F. Santibanez; Tatjana Srdic Rajic ; Nikolić, Katarina M. | Conference Paper | Mp. category will be shown later |
| 2021 | Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterization | Ružić, Dušan ; Petković, Miloš ; Gul, Sheraz; Santibanez, Juan ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2021 | I1-imidazoline receptor ligand inhibits P-glycoprotein efflux in pancreatic ductal adenocarcinoma cells | Ostojić, Marija ; Srdić-Rajić, Tatjana ; Pavlović, Marijana ; Živić, Kristina ; Jelena Grahovac | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2021 | Nischarin is expressed in pancreatic ductal adenocarcinoma and is a potential target for drug repurposing. | Grahovac, Jelena S ; Pavlovic, Marijana ; Ostojic, Marija Z ; Zivic, Kristina ; Galun, Danijel A; Srdic-Rajic, Tatjana V | Conference Paper | Mp. category will be shown later |
| 2020 | Potential anti-melanoma activity of Imidazoline I1 receptor agonists | Vidosavljević, Marija Z. ; Tatjana Srdić-Rajić ; Olivera Mitrović-Ajtić ; Marko Jevrić ; Jelena Grahovac | Konferencijski rad | 34  MNO za medicinske nauke (25.12.2024.)M34 - Saopštenje sa međ. skupa štampano u izvodu |